Report Detail

Other Global Castration Resistant Prostate Cancer Treatment Market Size, Status and Forecast 2019-2025

  • RnM2748658
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 96 Pages
  • |
  • QYResearch
  • |
  • Other

Global Castration Resistant Prostate Cancer Treatment Market Size, Status and Forecast 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Hormonal Therapy
      • 1.4.3 Adding An Anti-Androgen
      • 1.4.4 Stopping An Anti-Androgen
      • 1.4.5 Estrogens
      • 1.4.6 Chemotherapy
      • 1.4.7 Radiation Therapy
      • 1.4.8 Others
    • 1.5 Market by Application
      • 1.5.1 Global Castration Resistant Prostate Cancer Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospital
      • 1.5.3 Ambulatory Surgical Centers
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Castration Resistant Prostate Cancer Treatment Market Size
    • 2.2 Castration Resistant Prostate Cancer Treatment Growth Trends by Regions
      • 2.2.1 Castration Resistant Prostate Cancer Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Castration Resistant Prostate Cancer Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Castration Resistant Prostate Cancer Treatment Market Size by Manufacturers
      • 3.1.1 Global Castration Resistant Prostate Cancer Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Castration Resistant Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Castration Resistant Prostate Cancer Treatment Key Players Head office and Area Served
    • 3.3 Key Players Castration Resistant Prostate Cancer Treatment Product/Solution/Service
    • 3.4 Date of Enter into Castration Resistant Prostate Cancer Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Castration Resistant Prostate Cancer Treatment Market Size by Type (2014-2019)
    • 4.2 Global Castration Resistant Prostate Cancer Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Castration Resistant Prostate Cancer Treatment Market Size (2014-2019)
    • 5.2 Castration Resistant Prostate Cancer Treatment Key Players in United States
    • 5.3 United States Castration Resistant Prostate Cancer Treatment Market Size by Type
    • 5.4 United States Castration Resistant Prostate Cancer Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Castration Resistant Prostate Cancer Treatment Market Size (2014-2019)
    • 6.2 Castration Resistant Prostate Cancer Treatment Key Players in Europe
    • 6.3 Europe Castration Resistant Prostate Cancer Treatment Market Size by Type
    • 6.4 Europe Castration Resistant Prostate Cancer Treatment Market Size by Application

    7 China

    • 7.1 China Castration Resistant Prostate Cancer Treatment Market Size (2014-2019)
    • 7.2 Castration Resistant Prostate Cancer Treatment Key Players in China
    • 7.3 China Castration Resistant Prostate Cancer Treatment Market Size by Type
    • 7.4 China Castration Resistant Prostate Cancer Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Castration Resistant Prostate Cancer Treatment Market Size (2014-2019)
    • 8.2 Castration Resistant Prostate Cancer Treatment Key Players in Japan
    • 8.3 Japan Castration Resistant Prostate Cancer Treatment Market Size by Type
    • 8.4 Japan Castration Resistant Prostate Cancer Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Castration Resistant Prostate Cancer Treatment Market Size (2014-2019)
    • 9.2 Castration Resistant Prostate Cancer Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Castration Resistant Prostate Cancer Treatment Market Size by Type
    • 9.4 Southeast Asia Castration Resistant Prostate Cancer Treatment Market Size by Application

    10 India

    • 10.1 India Castration Resistant Prostate Cancer Treatment Market Size (2014-2019)
    • 10.2 Castration Resistant Prostate Cancer Treatment Key Players in India
    • 10.3 India Castration Resistant Prostate Cancer Treatment Market Size by Type
    • 10.4 India Castration Resistant Prostate Cancer Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Castration Resistant Prostate Cancer Treatment Market Size (2014-2019)
    • 11.2 Castration Resistant Prostate Cancer Treatment Key Players in Central & South America
    • 11.3 Central & South America Castration Resistant Prostate Cancer Treatment Market Size by Type
    • 11.4 Central & South America Castration Resistant Prostate Cancer Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Active Biotech
      • 12.1.1 Active Biotech Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Castration Resistant Prostate Cancer Treatment Introduction
      • 12.1.4 Active Biotech Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
      • 12.1.5 Active Biotech Recent Development
    • 12.2 Diagnocure
      • 12.2.1 Diagnocure Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Castration Resistant Prostate Cancer Treatment Introduction
      • 12.2.4 Diagnocure Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
      • 12.2.5 Diagnocure Recent Development
    • 12.3 Glaxosmithkline
      • 12.3.1 Glaxosmithkline Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Castration Resistant Prostate Cancer Treatment Introduction
      • 12.3.4 Glaxosmithkline Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
      • 12.3.5 Glaxosmithkline Recent Development
    • 12.4 Northwest Biotherapeutics
      • 12.4.1 Northwest Biotherapeutics Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Castration Resistant Prostate Cancer Treatment Introduction
      • 12.4.4 Northwest Biotherapeutics Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
      • 12.4.5 Northwest Biotherapeutics Recent Development
    • 12.5 Millennium Pharmaceuticals
      • 12.5.1 Millennium Pharmaceuticals Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Castration Resistant Prostate Cancer Treatment Introduction
      • 12.5.4 Millennium Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
      • 12.5.5 Millennium Pharmaceuticals Recent Development
    • 12.6 Hologic
      • 12.6.1 Hologic Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Castration Resistant Prostate Cancer Treatment Introduction
      • 12.6.4 Hologic Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
      • 12.6.5 Hologic Recent Development
    • 12.7 Spectrum Pharmaceuticals
      • 12.7.1 Spectrum Pharmaceuticals Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Castration Resistant Prostate Cancer Treatment Introduction
      • 12.7.4 Spectrum Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
      • 12.7.5 Spectrum Pharmaceuticals Recent Development
    • 12.8 Abbott Laboratories
      • 12.8.1 Abbott Laboratories Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Castration Resistant Prostate Cancer Treatment Introduction
      • 12.8.4 Abbott Laboratories Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
      • 12.8.5 Abbott Laboratories Recent Development
    • 12.9 Bayer Healthcare Pharmaceuticals
      • 12.9.1 Bayer Healthcare Pharmaceuticals Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Castration Resistant Prostate Cancer Treatment Introduction
      • 12.9.4 Bayer Healthcare Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
      • 12.9.5 Bayer Healthcare Pharmaceuticals Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Prostate cancer can be defined as it is a form of cancer that develops into male reproductive system. Most of the prostate cancer are slow growing and stable but sometimes it can spread from prostate (gland) to other part of body such as bone and lymph node. Initially prostate cancer does not pose any symptom but in severe cases it can cause pain during urination and can cause problem during sexual intercourse. Castration resistant prostate cancer is referred to as a prostate cancer that is spread to other parts of body and is resistant to medical or surgical treatment. Risk factor for castration resistant prostate cancer includes genetic predisposition, geriatric population, unhygienic diet, medication exposure and many sexual partners. Diagnosis for the detection of castration resistant prostate cancer includes prostate imaging, biopsy, tumor marker and staging test. Crucial factor about castration resistant prostate cancer is that it is resistant to medical and surgical treatment.  However, other treatment options that are available in the market include hormone therapy, immune modulation, antiangiogenic treatment and bone targeted therapies.
      North America dominates the global market for castration resistant prostate cancer treatment due to presence of large prostate cancer population in this region. Moreover, increasing demand of diagnostic test, increasing awareness among people and initiative taken by the federal government also accounted for the market growth in North American region. Europe represents the second position in the global castration resistant prostate cancer treatment market due to presence of large geriatric population base in European region. Asia-Pacific is considered as an untapped market due to lack of awareness and lack of proper healthcare facilities in some Asian countries. Asian market growth will be fuelled by the presence of untapped opportunities due to extensive increase in the healthcare infrastructure (healthcare cost, healthcare facility and healthcare budget). Similarly, Asia-Pacific is considered as an emerging market during the study period due to growing market penetration in this region.
      In 2018, the global Castration Resistant Prostate Cancer Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Castration Resistant Prostate Cancer Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Castration Resistant Prostate Cancer Treatment development in United States, Europe and China.

      The key players covered in this study
      Active Biotech
      Diagnocure
      Glaxosmithkline
      Northwest Biotherapeutics
      Millennium Pharmaceuticals
      Hologic
      Spectrum Pharmaceuticals
      Abbott Laboratories
      Bayer Healthcare Pharmaceuticals

      Market segment by Type, the product can be split into
      Hormonal Therapy
      Adding An Anti-Androgen
      Stopping An Anti-Androgen
      Estrogens
      Chemotherapy
      Radiation Therapy
      Others

      Market segment by Application, split into
      Hospital
      Ambulatory Surgical Centers

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Castration Resistant Prostate Cancer Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Castration Resistant Prostate Cancer Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Castration Resistant Prostate Cancer Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Castration Resistant Prostate Cancer Treatment . Industry analysis & Market Report on Castration Resistant Prostate Cancer Treatment is a syndicated market report, published as Global Castration Resistant Prostate Cancer Treatment Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Castration Resistant Prostate Cancer Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,123.66
      4,685.49
      6,247.32
      3,537.39
      5,306.08
      7,074.77
      422,253.00
      633,379.50
      844,506.00
      276,970.98
      415,456.47
      553,941.96
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report